Well-established German medical cannabis distributor with sales network into German pharmacies & other global markets is seeking a strategic equity partner to fuel expansion plans. Open to full divestiture.

Listing ID: 10196465022
Licence(s) Held: Narcotics Licence, GDP Distribution Licence

Seeking strategic investment of up to €2.5 million for continued growth and market expansion

Listing Details:
Licensed German medical cannabis wholesaler importing, exporting & distributing a range of medicinal cannabis product forms selling in Germany, as well as other global markets

Currently conducting import and distribution of dried flower, extracts, finished medical cannabis products and API in bulk and jars, processing, in-house branding and white labelling services, B2B and B2C sales

Operating from licensed, leased premises in a commercial building, incorporating offices and lab space to support imports, as well as a partner processing and storage facility

Experienced, industry-leading team with deep expertise navigating German, European and global medical cannabis markets, with a firm grasp on the recreational cannabis market opportunity in Germany and the rest of Europe

Company has differentiated digital infrastructure and online assets providing significant competitive advantage

Working with an increasing number of suppliers as a “launch pad” into the German market, via white-label packaging, distribution and market access services

Business is self-funded, lean and efficient, operating at a low monthly burn rate with zero debts

The company has expanded its sourcing network and its product portfolio

Company is cash flow positive and expected to generate €2.7 million in 2024 and €4.5 million in 2025

Great opportunity to tap into German’s cannabis market as the new act came into force in 2024 that cannabis is no longer classified as a narcotic which simplifies the supply chain

Company can also perform research on psychedelics under the existing licences

Looking for a strategic partner or a merger to build on its unique platform, further scaling commercial operations and expanding to meet clientele demands in Europe

Open to full divestiture